Pregunta del cliente
Which supplier and development conversations should happen in person?
Replantear la próxima decisión en torno a «¿Cómo hacer productiva una visita a China?»
Este caso anonimizado muestra cómo convertir una cuestión transfronteriza en evidencias, límites y próximos pasos más claros en torno a «¿Cómo hacer productiva una visita a China?».
Which supplier and development conversations should happen in person?
Which supplier and development conversations should happen in person?
The itinerary should protect the brand and clarify responsibilities before revealing detailed creative or product information.
Business Visit Planning → protected meeting brief → sample or supplier-screening gate
El caso público se presenta como una secuencia de decisiones y controles de evidencia, no como una promesa de proveedor, cotización o resultado final del proyecto.
Define what the buyer must learn or compare onsite.
Arrange meetings and observations around those decisions.
Keep timing, demonstrations, and live-site access explicitly conditional.
Convert the visit into comparable notes and follow-up priorities.
Proceso público ilustrativo. La secuencia exacta cambia según el encargo, las pruebas disponibles y el alcance aprobado.
The buyer needed to explore several product families, but brand, IP, quality, customization, and production questions did not belong to one generic supplier route.
We separated the commercial and development workstreams, mapped suitable clusters and partner types, prepared visit questions, and kept the follow-up route open until the meetings produced evidence.
The itinerary should protect the brand and clarify responsibilities before revealing detailed creative or product information.
Use the visit to decide which product routes deserve a protected brief, sample, or formal supplier conversation next.
The public case does not disclose the brand, IP, product theme, suppliers, MOQ, production status, quotations, or contract terms. Access depends on third-party confirmation.
Comparta la decisión, la evidencia que ya tiene y el riesgo que necesita reducir. Le ayudaremos a identificar el siguiente paso correcto.